How many people have been treated with hyperthermic intraperitoneal chemotherapy in Wales, and how many have been referred to England, in each year since 2017?
The Welsh Health Specialised Services Committee (WHSSC) is responsible for commissioning Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy on behalf of health boards in Wales. Its commissioning policies can be found at:
https://whssc.nhs.wales/commissioning/whssc-policies/cancer/hyperthermic-intraperitoneal-chemotherapy-hipec-and-cytoreductive-surgery-for-treatment-of-pseudomyxoma-peritonei-commissioning-policy-cp02-september-2015/
https://whssc.nhs.wales/commissioning/whssc-policies/cancer/cytoreductive-surgery-with-hyperthermic-intraperitoneal-chemotherapy-for-peritoneal-carcinomatosis-and-pseudomyxoma-peritonei-policy-position-statement-pp90-september-2015/
The Welsh Government does not routinely collect data on the number of patients referred for this technique. The technique is not available in Wales.